Monoclonal gammopathy is a clonal disorder of plasma cells or B-lymphocytes, characterized by the production of a M-protein detectable in serum or urine, and encompassing a spectrum from asymptomatic conditions (e.g., MGUS) to malignancies (e.g., multiple myeloma). This evidence concerns the gene MYOM2 and plasma cell myeloma.